You are browsing the global website, which contains information intended for residents outside of the United States of America (U.S.). This website is not country-specific and therefore may contain information that is not applicable to your country.
Rare Cells, with Single Cell Precision
We offer a menu of FDA-cleared and laboratory-developed tests (LDTs) used to detect and analyze circulating tumor cells in human blood with CELLSEARCH®. This minimally invasive liquid biopsy approach allows these tests to enable optimized patient care and comfort throughout the patient’s therapeutic journey.
Learn more about our Oncology portfolio
Learn more about our commitment in cell-based noninvasive prenatal testing (CB-NIPT)
Find out more about billing options
Learn more about setting up your account and ordering a test
If you already have an existing portal account, you can login here
Discover how our clinical lab service can support biopharma partners and clinical trials
Discover how our custom research lab service can support research projects
Single Cell Analysis
FFPE Analysis
View our complete list of Laboratory Developed Tests
Read the latest news from the Menarini Group
2011 - 11 - 30
Silicon Biosystems, Inc., a provider of specialized molecular and cellular biology technology, announced today that Baylor College of Medicine has agreed to purchase the company's DEPArray™ technology for use in research programs related to prenatal diagnostics and molecular oncology.
The decision to acquire the DEPArray™ technology at Baylor College of Medicine has been led by Dr. Arthur Beaudet, Chairman of the Department of Molecular and Human Genetics at Baylor.
Read More
Login